Drug Database
Back to search

United States· US:65841-658_1d7227b2-6052-40b4-bf22-29f18672ce08

Ramipril

A ramipril product containing ramipril, registered in United States by Zydus Lifesciences Limited. The same ATC class is registered in 18 of our 19 countries.

ATC C09AA05US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedRamiprilATCC09AA05REGISTER NO.US:65841-658_1d7227b2…PACKS LISTED10CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ramiprilAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ramipril is registered in 18 of 19 countries.

Countries holding a registration under ATC C09AA05 (ramipril), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 11 of them publish a price we can compare per daily dose
Search ramipril products by name

Ramipril · ATC C09AA05

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ramipril costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.026 in United States to $0.40 in Switzerland — a ×15 gap.

  • United States: $0.026 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Ramipril · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.40
  • ES Spain$0.098
  • FR France$0.096
  • IT Italy$0.073
  • US United States$0.026 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
RAMIPRIL
Manufacturer
Zydus Lifesciences Limited
Country
United States (US)
ATC code
C09AA05
ATC class
Ramipril
Defined daily dose
2.5 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 10

  • ndc11
    65841-658-01
  • ndc11
    65841-658-05
  • ndc11
    65841-658-06
  • ndc11
    6584165801
    100 CAPSULE in 1 BOTTLE (65841-658-01)
  • ndc11
    6584165805
    500 CAPSULE in 1 BOTTLE (65841-658-05)
  • ndc11
    6584165806
    30 CAPSULE in 1 BOTTLE (65841-658-06)
  • ndc11
    6584165816
    90 CAPSULE in 1 BOTTLE (65841-658-16)
  • ndc11
    6584165830
    10 BLISTER PACK in 1 CARTON (65841-658-30) / 10 CAPSULE in 1 BLISTER PACK
  • ndc11
    65841-658-16
  • ndc11
    65841-658-30

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

458 interactions on record for ramipril.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ramipril against other medicinesHow interaction checks work

Ramipril · interactions on record

458 records

  • 11 severe
  • 166 moderate
  • 17 minor
  • 184 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

80 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ramipril in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ramipril products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Lannapril, Ramipril 1a Pharma
  • Belgium · Ramipril Ab, Ramipril Eg
  • Bulgaria · Cardifriend, Cardifriend 10 Mg
  • Cyprus · Acapril, Ramimed
  • Czechia · Amprilan, Piramil
  • Germany · Delix, Delix P
  • Denmark · Alarimed, Polpril
  • Estonia · Ampril, Cardace
  • Spain · Acovil, Ramipril Alter Genéricos
  • Finland · Cardace, Ramipril Hexal
  • France · Ramipril Almus, Ramipril Arrow Generiques
  • United Kingdom (Northern Ireland) · Ramipril, Ramipril Accord Healthcare
  • Greece · Piramil, Ramisyn
  • Croatia · Ampril, Blocar
  • Hungary · Amprilan, Hartil
  • Ireland · Ramic, Ramilo
  • Iceland · Ramíl
  • Italy · Herzatec, Krupil
  • Lithuania · Ampril, Cardace
  • Luxembourg · Ramipril Eg, Tritace
  • Latvia · Cardace, Ramicor
  • Malta · Ramipril Aurobindo, Ramipril Tad
  • Netherlands · Ramipril Accord, Ramipril Aurobindo
  • Norway · Ramipril Actavis, Ramipril Hexal
  • Poland · Ampril, Aporami
  • Portugal · Ramipril Alter, Ramipril Aurovitas
  • Romania · Ampril, Ramipril Ac
  • Sweden · Ramiliv, Ramipril Aurobindo
  • Slovenia · Ampril, Piramil
  • Slovakia · Ampril, Piramil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ad2dd760-1ea4-4520-888a-d682b06a3c8a
GET /v1/drugs/ad2dd760-1ea4-4520-888a-d682b06a3c8a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10",
  "substance": "RAMIPRIL",
  "productndc": "65841-658",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA078832",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about ramipril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console